New FDA-approved ‘Wegovy HD’ offers triple the semaglutide dosage
The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long-term weight loss maintenance for adult patients. It is triple the previous maximum dose of 2.4 mg. This marks the fourth approval in the FDA’s National … Read more